Back to News
Market Impact: 0.2
William Blair Initiates Coverage of Vor Biopharma at Outperform
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
William Blair initiated coverage of Vor Biopharma with an Outperform recommendation on October 21, 2026. Vor closed at $19.03 on October 20, before the initiation; the article provides no post-initiation share reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
VOR0.45
More News
- Why is Resonac stock sliding today?
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- SpaceX is ripping higher after strong earnings. Analysts see more gains ahead
- +48%, +39%, +22%: Our AI just called these blue-chip breakouts
- JPMorgan says SpaceX will triple after huge third-quarter earnings beat
- Salesforce goes back to the M&A well to fortify a weaker business. Why it's a smart move